Invasive pneumococcal disease in England and Wales: vaccination implications

J Infect Dis. 2001 Jan 15;183(2):239-246. doi: 10.1086/317924. Epub 2000 Dec 21.

Abstract

Knowledge of the epidemiology of invasive pneumococcal disease (IPD) will aid in planning the use of pneumococcal vaccines. A United Kingdom (UK)-based surveillance in England and Wales (1995-1997) of 11,528 individuals with IPD and a local enhanced surveillance in the Oxford (UK) area (1995-1999) have been analyzed. IPD has a high attack rate in children, with 37.1-48.1 cases per 100,000 infants <1 year old per year, and in older persons, with 21.2-36.2 cases per 100,000 persons >65 years old per year, for England, Wales, and Oxford. The 7-valent conjugate vaccine includes serotypes causing < or =79% of IPD in children <5 years old, but only 66% in adults >65 years old. The data also indicate that IPD varies by serotype, age, and country, emphasizing that the epidemiology of IPD is heterogeneous and requires continued surveillance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Child
  • Child, Preschool
  • Drug Resistance, Microbial
  • England / epidemiology
  • Female
  • Humans
  • Incidence
  • Infant
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pneumococcal Infections / epidemiology*
  • Pneumococcal Infections / microbiology
  • Pneumococcal Infections / prevention & control*
  • Pneumococcal Vaccines* / immunology
  • Serotyping
  • Streptococcus pneumoniae / classification*
  • Streptococcus pneumoniae / isolation & purification
  • Vaccination*
  • Vaccines, Conjugate / immunology
  • Wales / epidemiology

Substances

  • Anti-Bacterial Agents
  • Pneumococcal Vaccines
  • Vaccines, Conjugate